STAAR Surgical (STAA) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
STAAR Surgical Reports First Quarter 2017 Results
May 3, 2017 4:01 PM EDTMONROVIA, Calif., May 3, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today reported financial results for the first quarter ended March 31, 2017.
First Quarter 2017 Overview
Quarterly Net Sales of $20.4 Million Up 6% from the Prior Year Quarter ICL Sales Up 16% and Units Up 20% from the Prior Year Quarter IOL Sales Down 9% and Units Flat from the Prior Year Quarter Gross Margin Improved to 71.6% of Sales from 67.4% of Sales... More